| Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer (NCT04948437) | National Taiwan University Hospital | 2021-08-19 |
| PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer (NCT04544111) | Memorial Sloan Kettering Cancer Center | 2020-09-02 |
| Psychological Impact of a Sophrological Accompaniment During the Announcement of Thyroid Cancer (NCT03639662) | Assistance Publique Hopitaux De Marseille | 2018-09-01 |
| Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer (NCT03630120) | H. Lee Moffitt Cancer Center and Research Institute | 2018-08-06 |
| Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in Follicular Thyroid Tumours (NCT05052359) | National University Health System, Singapore | 2018-01-01 |
| Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer (NCT01723202) | Bhavana Konda | 2012-11-07 |
| Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment (NCT01441154) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2011-09-20 |
| Sutent Adjunctive Treatment of Differentiated Thyroid Cancer (NCT00668811) | Medstar Health Research Institute | 2008-04-01 |
| Long-term Survival Outcomes of Total Thyroidectomy and Radioactive Iodine Therapy in Unilateral T3/T4 FTC (NCT06437873) | Dezhou Hospital Qilu Hospital of Shandong University | 2000-01-01 |
| Studies on Tumors of the Thyroid (NCT00001160) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1977-06-01 |